Skip to main content
Jonathan Head, MD, Family Medicine, Smyrna, TN

JonathanMHeadMD

Family Medicine Smyrna, TN

Physician

Dr. Head is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Head's full profile

Already have an account?

  • Office

    985 Industrial Blvd
    Smyrna, TN 37167
    Phone+1 615-984-1000
    Fax+1 615-984-1005

Education & Training

  • Valley Consortium for Medical Education Family Medicine
    Valley Consortium for Medical Education Family MedicineResidency, Family Medicine, 2001 - 2004
  • University of Alabama School of Medicine
    University of Alabama School of MedicineClass of 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2003 - Present
  • TN State Medical License
    TN State Medical License 2012 - 2026
  • IA State Medical License
    IA State Medical License 2006 - 2016
  • MN State Medical License
    MN State Medical License 2014 - 2014
  • NC State Medical License
    NC State Medical License 2004 - 2007
  • American Board of Family Medicine Family Medicine

Press Mentions

  • OncBioMune Pharmaceuticals, Inc. (OTCMKTS:OBMP) Files an 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    OncBioMune Pharmaceuticals, Inc. (OTCMKTS:OBMP) Files an 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersMarch 19th, 2019
  • OncBioMune CEO Dr. Jonathan Head Speaking at 2018 Global Summit on Genitourinary Malignancies
    OncBioMune CEO Dr. Jonathan Head Speaking at 2018 Global Summit on Genitourinary MalignanciesOctober 31st, 2018
  • ProscaVax Vaccine Stopped Prostate Cancer Progression in 80% of Patients, Phase 1 Trial Shows
    ProscaVax Vaccine Stopped Prostate Cancer Progression in 80% of Patients, Phase 1 Trial ShowsNovember 14th, 2017
  • Join now to see all